Marshall Wace LLP Invests $213,000 in Context Therapeutics Inc. (NASDAQ:CNTX)
Marshall Wace LLP acquired a new stake in Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 203,286 shares of the company’s stock, valued at approximately $213,000. Other hedge funds and […]
Marshall Wace LLP acquired a new stake in Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 203,286 shares of the company’s stock, valued at approximately $213,000. Other hedge funds and […]
